🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Jeremy Grantham’s MET Holdings & Trades

First Buy
Q2 2013
Duration Held
35 Quarters
Largest Add
Q2 2013
+1.07 M Shares
Current Position
75,345 Shares
$5.95 M Value

Jeremy Grantham's MET Position Overview

Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 75,345 shares of MetLife, Inc. (MET) worth $5.95 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 35 quarters.

Based on 13F filings, Jeremy Grantham has maintained a strategic position in MET, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 372,200 shares. Largest reduction occurred in Q1 2014, reducing 326,813 shares.

Analysis based on 13F filings available since 2013 Q2

Jeremy Grantham's MetLife (MET) Holding Value Over Time

Track share changes against reported price movement

Quarterly MetLife (MET) Trades by Jeremy Grantham

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +539 Add 0.72% 75,345 $78.94
Q3 2025 +45,447 Add 154.80% 74,806 $82.37
Q2 2025 +13,014 Add 79.62% 29,359 $80.42
Q1 2025 +481 Add 3.03% 16,345 $80.29
Q4 2024 +1,044 Add 7.04% 15,864 $81.88
Q3 2024 +14,820 New Buy 14,820 $82.48
Q4 2023 -210,589 Sold Out 0 $0.00
Q3 2023 -44,658 Reduce 17.50% 210,589 $62.91
Q2 2023 +17,431 Add 7.33% 255,247 $56.53
Q1 2023 -59,700 Reduce 20.07% 237,816 $57.94
Q4 2022 -161,584 Reduce 35.20% 297,516 $72.37
Q3 2022 +11,145 Add 2.49% 459,100 $60.78
Q2 2022 -188,126 Reduce 29.58% 447,955 $62.79
Q1 2022 -124,919 Reduce 16.42% 636,081 $70.28
Q4 2021 +233,700 Add 44.32% 761,000 $62.49
Q3 2021 +46,700 Add 9.72% 527,300 $61.73
Q2 2021 +29,700 Add 6.59% 480,600 $59.85
Q1 2021 +78,700 Add 21.14% 450,900 $60.79
Q4 2020 +372,200 New Buy 372,200 $46.95
Q1 2017 -14,398 Sold Out 0 $0.00
Q4 2016 +2,336 Add 19.37% 14,398 $48.06
Q3 2016 -6,395 Reduce 34.65% 12,062 $39.63
Q2 2016 -5,498 Reduce 22.95% 18,457 $35.49
Q1 2016 +5,476 Add 29.63% 23,955 $39.16
Q4 2015 -75,960 Reduce 80.43% 18,479 $42.97
Q3 2015 -189,203 Reduce 66.70% 94,439 $42.03
Q2 2015 -70,910 Reduce 20.00% 283,642 $49.90
Q1 2015 +23,750 Add 7.18% 354,552 $45.05
Q4 2014 -57,782 Reduce 14.87% 330,802 $48.21
Q3 2014 +57,931 Add 17.52% 388,584 $47.88
Q2 2014 -215,993 Reduce 39.51% 330,653 $49.52
Q1 2014 -326,813 Reduce 37.42% 546,646 $47.06
Q4 2013 -183,922 Reduce 17.39% 873,459 $48.06
Q3 2013 -11,348 Reduce 1.06% 1.06 M $41.84
Q2 2013 +1.07 M Add 0.00% 1.07 M $40.78

Jeremy Grantham's MetLife Investment FAQs

Jeremy Grantham first purchased MetLife, Inc. (MET) in Q2 2013, acquiring 1,068,729 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham has held MetLife, Inc. (MET) for 35 quarters since Q2 2013.

Jeremy Grantham's largest addition to MetLife, Inc. (MET) was in Q2 2013, adding 1,068,729 shares worth $43.59 M.

According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 75,345 shares of MetLife, Inc. (MET), valued at approximately $5.95 M.

As of the Q4 2025 filing, MetLife, Inc. (MET) represents approximately 0.02% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.

Jeremy Grantham's peak holding in MetLife, Inc. (MET) was 1,068,729 shares, as reported at the end of Q2 2013.